CP60 Stock Overview Develops, manufactures, and markets contact lens wearers. More details
Rewards Risk Analysis No risks detected for CP60 from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
The Cooper Companies, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Cooper Companies Historical stock prices Current Share Price US$88.90 52 Week High US$101.00 52 Week Low US$78.55 Beta 0.97 1 Month Change -5.07% 3 Month Change -9.61% 1 Year Change 6.63% 3 Year Change 2.72% 5 Year Change 24.34% Change since IPO 5,682.11%
Recent News & Updates
The Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2025 Dec 06
The Cooper Companies, Inc. to Report Q4, 2024 Results on Dec 05, 2024 Nov 13
Third quarter 2024 earnings released: EPS: US$0.52 (vs US$0.43 in 3Q 2023) Aug 29
The Cooper Companies, Inc. Raises Earnings Guidance for the Fourth Quarter and Fiscal Year 2024 Aug 29
The Cooper Companies, Inc. to Report Q3, 2024 Results on Aug 28, 2024 Aug 07
Second quarter 2024 earnings released: EPS: US$0.45 (vs US$0.20 in 2Q 2023) Jun 05 See more updates
The Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2025 Dec 06
The Cooper Companies, Inc. to Report Q4, 2024 Results on Dec 05, 2024 Nov 13
Third quarter 2024 earnings released: EPS: US$0.52 (vs US$0.43 in 3Q 2023) Aug 29
The Cooper Companies, Inc. Raises Earnings Guidance for the Fourth Quarter and Fiscal Year 2024 Aug 29
The Cooper Companies, Inc. to Report Q3, 2024 Results on Aug 28, 2024 Aug 07
Second quarter 2024 earnings released: EPS: US$0.45 (vs US$0.20 in 2Q 2023) Jun 05
The Cooper Companies, Inc. Raises Earnings Guidance for the Fiscal Year 2024 May 31
The Cooper Companies, Inc. to Report Q2, 2024 Results on May 30, 2024 May 01 The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024 Mar 01
Girard Sharp LLP and Sauder Schelkopf LLC Files Lawsuit Against Coopersurgical, Inc. and the Cooper Companies, Inc Feb 22
The Cooper Companies, Inc. Announces Resignation of Gary S. Petersmeyer from Board of Directors Feb 03 Slater Vecchio LLP Files Class Action Lawsuit Against LifeGroup Global LLC, The Cooper Companies Inc, CooperSurgical Inc, and CooperSurgical Canada Inc Jan 31
Now 20% undervalued Jan 30
The Cooper Companies, Inc. to Report Q1, 2024 Results on Feb 29, 2024 Jan 26
Now 20% undervalued Jan 18
The Cooper Companies, Inc., Annual General Meeting, Mar 19, 2024 Dec 20
The Cooper Companies, Inc. Announces Retirement of Gary S. Petersmeyer as Director Dec 14
Now 20% undervalued after recent price drop Dec 12
Full year 2023 earnings released: EPS: US$5.91 (vs US$7.83 in FY 2022) Dec 08
The Cooper Companies, Inc. Provides Revenue Guidance for the Fiscal Year 2024 Dec 08
CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors, Effective December 1, 2023 Dec 01
The Cooper Companies, Inc. to Report Q4, 2023 Results on Dec 07, 2023 Nov 03
The Cooper Companies, Inc. (NasdaqGS:COO) acquired Bakri Postpartum Balloon, Cervical Ripening Balloon, Doppler Blood Flow Monitor portfolio and gynecology surgery markets of Cook Medical Incorporated for $300 million. Nov 02
The Cooper Companies, Inc. Updates Revenue Guidance for the Year 2023 Sep 01
Third quarter 2023 earnings released: EPS: US$1.71 (vs US$2.00 in 3Q 2022) Aug 31
Upcoming dividend of US$0.03 per share Jul 19
The Cooper Companies, Inc. Provides Revenue Guidance for the Year 2023 Jun 03
Second quarter 2023 earnings released: EPS: US$0.80 (vs US$2.57 in 2Q 2022) Jun 02
Senior VP & Chief Accounting Officer recently sold €341k worth of stock Apr 05
President of CooperVision recently sold €391k worth of stock Mar 10
First quarter 2023 earnings released: EPS: US$1.70 (vs US$1.93 in 1Q 2022) Mar 03
The Cooper Companies, Inc. to Report Q1, 2023 Results on Mar 02, 2023 Feb 03
Upcoming dividend of US$0.03 per share Jan 13
The Cooper Companies, Inc., Annual General Meeting, Mar 15, 2023 Dec 20
CooperCompanies Declares Cash Dividend, Payable on February 10, 2023 Dec 16
Full year 2022 earnings released: EPS: US$7.76 (vs US$59.85 in FY 2021) Dec 09
The Cooper Companies, Inc. Initiates Earnings Guidance for the Fiscal Year 2023 Dec 09
The Cooper Companies, Inc. to Report Q4, 2022 Results on Dec 08, 2022 Nov 04
the Cooper Companies, Inc. Appoints Cynthia Lucchese to Board of Directors Oct 06
Third quarter 2022 earnings released: EPS: US$1.98 (vs US$12.49 in 3Q 2021) Sep 02
the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full year 2022 Sep 02
the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full Year Year 2022 Sep 01
CooperCompanies Appoints Nicholas Khadder as Its General Counsel and Corporate Secretary Aug 10
The Cooper Companies, Inc. to Report Q3, 2022 Results on Aug 31, 2022 Jul 28
Upcoming dividend of US$0.03 per share Jul 19
CooperCompanies Declares Semi-Annual Cash Dividend, Payable on August 11, 2022 Jul 14
The Cooper Companies, Inc. Provides Consolidated Earnings Guidance for the Third Quarter, Fourth Quarter and Full Year of Fiscal 2022 Jun 04
Second quarter 2022 earnings released: EPS: US$2.55 (vs US$2.39 in 2Q 2021) Jun 03
Independent Director recently sold €113k worth of stock Apr 13
The Cooper Companies, Inc. Provides Revenue Earnings Guidance for the Fiscal Year 2022 Mar 05
First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Mar 05
The Cooper Companies, Inc. (NYSE:COO) signed a binding letter of intent to acquire Reproductive Health Business of Cook Medical for $880 million. Feb 08
The Cooper Companies, Inc. to Report Q1, 2022 Results on Mar 03, 2022 Jan 28
Insufficient new directors Jan 19
Inaugural dividend of US$0.03 per share Jan 13
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Dec 03
The Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2022 Dec 03
Independent Director recently sold €170k worth of stock Sep 16
Third quarter 2021 earnings released: EPS US$12.37 (vs US$1.12 in 3Q 2020) Sep 04
The Cooper Companies, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of Fiscal 2021 Sep 03
CooperCompanies Announces MiSight® Approval from Chinese National Medical Products Administration Aug 13
Inaugural dividend of US$0.03 per share Jul 19
Independent Director recently sold €139k worth of stock Jul 15 The Cooper Companies, Inc.(NYSE:COO) dropped from Russell 1000 Growth-Defensive Index
Second quarter 2021 earnings released: EPS US$2.36 (vs US$0.23 in 2Q 2020) Jun 05
the Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2021 Jun 04
Revenue beats expectations Mar 05
First quarter 2021 earnings released: EPS US$42.28 (vs US$1.84 in 1Q 2020) Mar 05
New 90-day high: €323 Feb 24
New 90-day high: €320 Feb 07
The Cooper Companies, Inc. to Report Q1, 2021 Results on Mar 04, 2021 Feb 05
EssilorLuxottica Société anonyme (ENXTPA:EL) and The Cooper Companies, Inc. (NYSE:COO) agreed to acquire SightGlass Vision from The Cooper Companies, Inc. (NYSE:COO). Feb 04
Legal Advisor has left the company Feb 03
Special Advisor to the CEO Robert Auerbach has left the company Feb 02
New 90-day high: €310 Jan 15
Full year 2020 earnings released: EPS US$4.86 Dec 14
Revenue beats expectations Dec 14
CooperCompanies Announces Board Changes Dec 11
Full year 2020 earnings released: EPS US$4.81 Dec 05
Revenue beats expectations Dec 05
The Cooper Companies, Inc. Votes to Elect Teresa S. Madden to Fill the New Director Position, with Effect from December 1, 2020 Nov 13
The Cooper Companies, Inc. to Report Q4, 2020 Results on Dec 03, 2020 Nov 04
Special Advisor to the CEO recently sold €756k worth of stock Oct 11
CooperVision Provides Six-Year Data from MiSight® 1 Day Study Oct 11
New 90-day high: €298 Oct 08
New 90-day high - €274 Sep 09
Third quarter earnings released Sep 06
The Cooper Companies, Inc. to Report Q3, 2020 Results on Sep 03, 2020 Aug 07
The Cooper Companies, Inc.(NYSE:COO) dropped from Russell 1000 Dynamic Index Jul 04 Shareholder Returns CP60 DE Medical Equipment DE Market 7D -4.8% -2.2% -1.1% 1Y 6.6% -7.2% 8.1%
See full shareholder returns
Return vs Market: CP60 underperformed the German Market which returned 9.2% over the past year.
Price Volatility Is CP60's price volatile compared to industry and market? CP60 volatility CP60 Average Weekly Movement 3.6% Medical Equipment Industry Average Movement 6.7% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.8% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: CP60 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: CP60's weekly volatility (4%) has been stable over the past year.
About the Company The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Show more The Cooper Companies, Inc. Fundamentals Summary How do Cooper Companies's earnings and revenue compare to its market cap? CP60 fundamental statistics Market cap €17.88b Earnings (TTM ) €374.06m Revenue (TTM ) €3.71b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) CP60 income statement (TTM ) Revenue US$3.90b Cost of Revenue US$1.30b Gross Profit US$2.60b Other Expenses US$2.20b Earnings US$392.30m
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
Mar 06, 2025
Earnings per share (EPS) 1.97 Gross Margin 66.64% Net Profit Margin 10.07% Debt/Equity Ratio 31.9%
How did CP60 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/17 07:13 End of Day Share Price 2024/12/17 00:00 Earnings 2024/10/31 Annual Earnings 2024/10/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources The Cooper Companies, Inc. is covered by 35 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jeffrey Johnson Baird Ishan Majumdar Baptista Research Joanne Wuensch BMO Capital Markets Equity Research
Show 32 more analysts 
